课题基金 / 基金详情

Timing of Initiation of Combined Antiretroviral Therapy in Treatment Naive HIV-Hepatitis C Co-infected Patients: A Collaborative Cohort Study and Cost-Effectiveness Analysis

Timing of Initiation of Combined Antiretroviral Therapy in Treatment Naive HIV-Hepatitis C Co-infected Patients: A Collaborative Cohort Study and Cost-Effectiveness Analysis
初次治疗 HIV-丙型肝炎合并感染患者的联合抗逆转录病毒治疗的启动时机：协作队列研究和成本效益分析
批准号：
272907
负责人：
Rossi Carmine
金额：
$7.65万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-10-01 至 2015-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=272907&lang=en
关键词：
Administrative Data Cd4 Lymphocyte Count Cohort Study Combined Antiretroviral Therapy Cost-Effectiveness Analysis Epidemiology Hepatitis C Infection Hiv Infection Liver Disease Treatment Outcomes

项目摘要

项目成果

Rossi Carmine的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In Canada, infection with both HIV and the hepatitis C virus has become an important issue. Since the introduction of HIV treatment, there has been a decrease in mortality from AIDS in HIV-infected people. However, as life expectancies increased, sickness
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of chronic hepatitis C virus (HCV) direct-acting antiviral therapy on extrahepatic manifestations among HIV co-infected British Columbians engaged in clinical care
Real-world effectiveness of direct-acting antiviral therapy for chronic hepatitis C among HIV co-infected Canadians receiving clinical care
Population-level impact of direct-acting antiviral (DAA) therapies for chronic hepatitis C on extrahepatic manifestations
Rates and Risk Factors for Hepatitis C Re-Infection or Late Relapse after Sustained Virologic Response to Treatment among HIV Co-Infected Canadians